Funding News
March 1, 2000
Funding News
The Lustgarten Foundation for Pancreatic Research was founded in November 1998 in order to advance the scientific and medical research related to the prevention, diagnosis, treatment, and cure of pancreatic cancer. The goals of the foundation are to: 1) increase funding and support of research into the biological mechanisms and clinical strategies related to the prevention, diagnosis, and treatment of cancer of the gastrointestinal tract with primary emphasis on adenocarcinoma of the pancreas; 2) facilitate and enhance the dialog among members of the medical and scientific communities about basic and clinical research efforts that relate to pancreatic cancer; 3) advocate an increase in the annual budget of the National Cancer Institute with emphasis on research related to pancreatic cancer; 4) heighten the public’s awareness of pancreatic cancer diagnosis, treatment, and prevention; and 5) provide informational support for pancreatic cancer patients, their families, and friends.
The Lustgarten Foundation for Pancreatic Cancer Research has awarded more than $2.7 million to nine researchers at major cancer research institutions. These grants were awarded in January and July of 1999. Although applications for the next round of grants are not yet available, the Lustgarten Foundation Web site (www.lustgarten.org) indicates that preparations are being made for the coming year. Interested researchers should check the foundation Web site in the future for information about the application process and copies of the application forms.
American Brain Tumor Association
The American Brain Tumor Association (ABTA) (www.abta.org) is a not-for-profit, independent organization dedicated to eliminating brain tumors by funding and encouraging research. The association also provides educational materials and objective resource information to patients, their families, and the medical professionals who treat them, promotes excellence in patient care, and advocates the investigation of novel treatment approaches.
The post-doctoral research fellowship program of the ABTA is supported by private donations and is intended to support talented, bright young researchers who are mentored by leaders in the field of neuro-oncology research. The ABTA Board of Directors recently committed to funding 13 post-doctoral fellows. This included eight new awards in the amount of $60,000 each, payable over two years, and five other continuing fellows who received awards the previous year.
The ABTA provides funding for translational research that is intended to take knowledge gained from basic science research of brain cancer into clinical application. Proven theories and observations should be used to design and prepare therapies for human testing.
Last year the ABTA awarded two $50,000 one-year translational research awards—one to develop a new method of treatment for gliomas and one to explore a potential new treatment for medulloblastoma in children.
Applications for next year’s ABTA post-doctoral research fellowships and translational grants can be obtained from the ABTA office by calling (847) 827-9910 or requests may be sent via e-mail to [email protected].
Medical Student Summer Research Fellowships are also provided by the ABTA. This unique research program provides the means for medical students to spend this summer in neuro-oncology research laboratories under expert mentorship. Department chairs interested in this program or researchers wishing to mentor a student during the summer of 2000 should contact the ABTA office at (847) 827-9910.
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content